Point Mutations in Anthrax Protective Antigen that Block Translocation

87Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The protective antigen (PA) moiety of anthrax toxin delivers the toxin's enzymatic moieties to the cytosol of mammalian cells by a mechanism associated with its ability to heptamerize and form a transmembrane pore. Here we report that mutations in Lys-397, Asp-425, or Phe-427 ablate killing of CHO-K1 cells by a cytotoxic PA ligand. These mutations blocked PA's ability to mediate pore formation and translocation in cells but had no effect on its receptor binding, proteolytic activation, or ability to oligomerize and bind the toxin's enzymatic moieties. The mutation-sensitive residues lie in the 2β 7-2β8, and 2β10-2β11 loops of domain 2 and are distant both in primary structure and topography from the 2β2-2β3 loop, which is believed to participate in formation of a transmembrane β-barrel. These results suggest that Lys-397, Asp-425, and Phe-427 participate in conformational rearrangements of a heptameric pore precursor that are necessary for pore formation and translocation. Identification of these residues will aid in elucidating the mechanism of translocation and may be useful in developing therapeutic and prophylactic agents against anthrax.

Cite

CITATION STYLE

APA

Sellman, B. R., Nassi, S., & Collier, R. J. (2001). Point Mutations in Anthrax Protective Antigen that Block Translocation. Journal of Biological Chemistry, 276(11), 8371–8376. https://doi.org/10.1074/jbc.M008309200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free